Seguir
Irene Bonafonte-Pardàs
Irene Bonafonte-Pardàs
ICB (Helmholtz Zentrum München)
Dirección de correo verificada de helmholtz-munich.de
Título
Citado por
Citado por
Año
Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19
A Julià, I Bonafonte-Pardàs, A Gómez, M López-Lasanta, ...
Scientific reports 11 (1), 1-14, 2021
162021
B cells orchestrate tolerance to the neuromyelitis optica autoantigen AQP4
AM Afzali, L Nirschl, C Sie, M Pfaller, O Ulianov, T Hassler, C Federle, ...
Nature, 1-9, 2024
12024
Blocking of the CD80/86 axis as a therapeutic approach to prevent progression to more severe forms of COVID-19
A Julià, I Bonafonte, A Gómez, M López-Lasanta, M López-Corbeto, ...
arXiv preprint arXiv:2005.10055, 2020
12020
Large-scale characterization of cell niches in spatial atlases using bio-inspired graph learning
S Birk, I Bonafonte-Pardàs, AM Feriz, A Boxall, E Agirre, F Memi, ...
bioRxiv, 2024.02. 21.581428, 2024
2024
Analyzing the contribution of different passively collected data to predict Stress and Depression
I Bonafonte, C Bustos, A Larrazolo, GLM Luna, AG Arenas, X Baro, ...
arXiv preprint arXiv:2310.13607, 2023
2023
Identification of Immunological Processes Associated with the Response to Abatacept in Rheumatoid Arthritis Using Longitudinal Blood RNA-seq Analysis
A Julia, ML Lasanta, A Gomez, I Bonafonte, R Sanmarti, C Marras, ...
ARTHRITIS & RHEUMATOLOGY 71, 2019
2019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–6